Benefits versus risk profile of buparlisib for the treatment of breast cancer.
Patsouris A, Augereau P, Frenel JS, Robert M, Gourmelon C, Bourbouloux E, Berton-Rigaud D, Chevalier LM, Campone M.
Patsouris A, et al. Among authors: frenel js.
Expert Opin Drug Saf. 2019 Jul;18(7):553-562. doi: 10.1080/14740338.2019.1623877.
Expert Opin Drug Saf. 2019.
PMID: 31159599
Review.